CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Aurobindo Pharma Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Aurobindo Pharma Ltd
Water Mark Building, Plot No. 11
Survey no.9, Kondapur, Hitech City
Phone: +91 4066725000p:+91 4066725000 HYDERABAD, 500032  India Ticker: AUROPHARMAAUROPHARMA
Business Summary
Aurobindo Pharma Limited is an India-based pharmaceutical company. The Company is principally engaged in manufacturing and marketing of active pharmaceutical ingredients, branded pharmaceuticals, generic pharmaceuticals, and related services. Its Key therapeutic segments include Central nervous systems (CNS), Antiretrovirals (ARVs), Cardiovascular (CVS), SSP - Orals and Sterile, Anti-infectives, Anti-diabetics and Cephalosporins - Orals. It is engaged in developing a range of oncology and hormonal products. It is developing topical as well as transdermal products in the dermatology therapeutic segment. The Company is marketing its products globally in approximately 150 countries. The Company's subsidiaries include APL Healthcare Limited, Auronext Pharma Private Limited, Auro Peptides Limited, APL Pharma Thai Limited, Auro Pharma Inc, Aurobindo Pharma (Malta) Limited, APL Swift Services (Malta) Limited, Aurobindo Pharma Industria Farmaceutica Ltda, and others.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/20243/31/2024Yes---Yes

Industries
SIC Code Description
2834 Pharmaceutical preparations
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Non-Executive Independent Chairman of the Board Mangalam R.Kumar 62 4/1/2024 4/1/2024
Executive Vice Chairman of the Board, Managing Director, Promoter K. NityanandaReddy 65 1/1/2022
Chief Financial Officer SanthanamSubramanian 7/1/2014 7/1/2014
6 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Eugia Pharma B.V. Basisweg 10 AMSTERDAM Netherlands
Aurobindo Pharma B.V. Baarnsche dijk 1 BAARN NL
AXIS Clinicals Limited 1-121/1, Survey No.66 (Part) & 67(Part) Hyderabad India
10 additional Subsidiary records available in full report.

Business Names
Business Name
524804
Acrotech Biopharma LLC
Actavis B.V.
83 additional Business Names available in full report.

General Information
Number of Employees: 8,797 (As of 3/31/2024)
Outstanding Shares: 580,801,623 (As of 9/30/2024)
Shareholders: 244,575
Stock Exchange: NSE
Federal Tax Id: 000002874
Fax Number: +91 4023741080


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, November 22, 2024